rate of rupture compared to a single aneurysm and requires multiple operations with an increase in associated costs.
Patients
From September 2010 to October 2015, 33 patients with multiple intracranial aneurysms were hospitalized into the First Affiliated Hospital of Zhengzhou University, and treated with one-stage endovascular embolization. Written informed consent was obtained from all the patients for the publication of this article and any accompanying images. This study was approved by the Ethics Committee of The First Affiliated Hospital of Zhengzhou University.
There were 13 men and 20 women (aged from 34 to 77 years) included in the study. Among these 33 patients, 21 patients were treated due to spontaneous SAH, including 19 cases of first bleeding and two cases of re-bleeding. Of these 21 patients with SAH, there were 12 cases of Hunt and Hess (H&H) grade I (asymptomatic or mild headache), six cases of Hunt and Hess grade II (moderate to severe headache), and three cases of Hunt and Hess grade III (drowsiness/confusion). For the remaining 12 patients, aneurysms were found during a health check.
Aneurysm Identification
The 33 patients were examined prior to the procedure using digital subtraction angiography (DSA) and three-dimensional (3D) reconstruction of rotational DSA. A total of 72 aneurysms were found. 28 of the patients had two aneurysms, four patients had three, and in one patient, four aneurysms existed. There were 12 wide-necked aneurysms in total. Fifty-one aneurysms were located on the anterior circulation, including 18 in the carotid-ophthalmic section, 26 in the intracavemous carotid, and two in the internal carotid artery bifurcation. Twenty-one aneurysms were located on posterior circulation, including four in the vertebral artery, three in the basilar trunk, one in the top basilar artery, and 13 in the posterior cerebral artery. The diameters of aneurysms were as follows: ≤3 mm (17 aneurysms); 3-10 mm (42 aneurysms); and >10 mm (13 aneurysms).
Identification of the Aneurysms Responsible for Bleeding
For MIA with SAH, the aneurysm responsible for bleeding was located at the site of blood clot using a computed tomography (CT) scan (Figure 1 ). If no blood clot was observed on the CT image, or if the aneurysms were multiple, the biggest or most irregular shaped aneurysm was identified as the bleeding source. Also the irregular shape of the daughter sac of the aneurysm had the most predictive value for determining the bleeding source. For MIA without SAH, the aneurysm responsible for bleeding was identified when cranial nerve symptoms were in accordance with the aneurysm's location. For asymptomatic MIA, aneurysms bigger than 5 mm in size were presumed to be the most likely to rupture and bleed.
Treatment
All patients were treated with one-stage embolization. The procedure was done under intubation anesthesia. The number, location, size, shape and relationship with the parent artery of the aneurysms were confirmed by DSA. Rotational DSA (3D reconstruction) was used to choose the best operating position. After heparinization, a 6 Fr guiding catheter (Cordis Neurovascular, Miami, FL, USA) was inserted into the target artery. The aneurysm responsible for bleeding was embolized first, followed by other aneurysms. Sixty narrownecked aneurysms were treated only with coils (Microplex (MicroVention, Aliso Viejo, CA, USA) or Axium (eV3, Irvine, CA,USA)), while 12 wide-necked aneurysms were embolized with the assistance of stents (9 Solitaire stents (eV3, Irvine, CA, USA) and 3 Enterprise stents (Cordis Neurovascular, Miami, FL,USA)). Among those treated using assistant stents, patients with unruptured aneurysms were given aspirin (100 mg/d) and clopidogrel (75 mg/d) for five days before intervention. For those patients with ruptured aneurysms, clopidogrel (300 mg) and aspirin (300 mg) were given at least two hours, but not more than three hours, prior to embolization. For patients with impaired consciousness, medication was administered rectally after anesthesia. After the procedure, clopidogrel (75 mg/d) was given for six weeks, and aspirin (100 mg/d) was given long-term.
Postoperative and Follow-up Evaluation
The degree of aneurysm occlusion was evaluated with DSA by two senior professional physicians immediately after the procedure, and then again, six months later. Modified Raymond classification was used to evaluate the patients as follows: (i) complete occlusion, when no contrast agent appears in the intracavity of the aneurysm; (ii) neck remnant, when contrast agent appears at the neck of the aneurysm; and (iii) aneurysm remnant, when part of the aneurysm fills with contrast agent (15) . The clinical outcome was assessed at discharge, and again after six months, using the modified Rankin Scale (mRS).
█ RESulTS
All embolization procedures were successful and all patients were discharged from hospital without permanent neural dysfunction. Immediately after the procedure, DSA showed 39 cases of aneurysms with complete occlusion, 27 with neck remnant, and 6 with aneurysm remnant. All of the stents were placed in an ideal location and no complications (such as stent occlusion, dislocation, endarterium tearing, obstruction of parent artery and its branches, aneurysm rupture or thromboembolism) occurred. An example of a one-stage embolization for three aneurysms is shown in Figure 2A -H.
All 33 patients received follow-up for a period of 3 to 28 months. For 27 patients, a mRS score of zero was observed, while six patients scored a mRS of one. For 28 patients, we performed DSA examination six months after the procedure.
One patient showed a neck remnant ( Figure 3A-D) , one showed a completely occluded aneurysm located at A1 section of left middle cerebral artery (MCA), and one patient had a completely occluded aneurysm located in the basilar artery. Despite this, there was no rupture or hemorrhage of these aneurysms.
█ DISCuSSION
Traditionally, multiple aneurysms required more than one operation to treat them effectively. Unfortunately, the risks associated with these procedures are relatively high as remnant aneurysms are likely to rupture during multiple operations. This risk becomes increased in patients with unstable blood pressure, or if other therapies (such as volume expansion, anticoagulation, dehydration, lumbar puncture, or ventricular drainage) are used. In addition, due to the multiple operations and lengthy hospitalization time, the costs associated with treating MIA are higher. A one-stage procedure could overcome these problems, by not only preventing the rupture of aneurysms, but also avoiding malpractice resulting from misjudgment of the responsible aneurysm.
Embolizing any unruptured aneurysms in MIA is necessary as they may rupture in the future causing a cerebral bleeding. aneurysms that underwent one-stage embolization, no procedure-related complications occurred, even if the aneurysm was bleeding. In addition, in all 33 patients, a mRS score of zero or one was recorded, indicating they were clinically asymptomatic or had no significant disabilities.
Another advantage of one-stage coiling embolization of MIA is that coiling avoids repeat general anesthesia and groin punctures compared with multiple separate procedures. Cost-effectiveness is another expected advantage. Coiling, particularly one-stage coiling, has been associated with a significantly shorter hospital stay and lower hospital expenses for patients with both ruptured and unruptured aneurysms compared to clipping procedures (3).
Despite these advantages, one-stage embolization requires a high level of skill and has its own limitations. For example, theoretically, vasospasm or vessel thromboembolism is likely to be triggered by the lengthy embolization operation with repeated intubation in a single parent artery. If rupture occurs, the procedure becomes even more difficult. In our study, the easier and distal aneurysms were embolized first, and the harder and proximal ones were treated later. This method should be employed in all one-stage embolization procedures to avoid vasospasm or intraoperative rupture of the aneurysm.
Determination of the aneurysm responsible for bleeding (i.e. the rupture site) is of significant importance in treating MIA, Cheong et al. analyzed more than 300 cases of multiple aneurysms and revealed that patients with a history of SAH have a formerly-unruptured-aneurysms rupture rate of 0.28% to 1.63% (1). In addition, Hino et al. treated 76 cases of multiple aneurysms and in six cases, the aneurysm responsible for bleeding was not correctly determined resulting in an additional four cases of cerebral hemorrhage (2). These results support the use of a one-stage embolization procedure for multiple aneurysms to prevent future ruptures and problems arising from incorrect determination of the rupture site.
To date, there have been many reported cases where multiple aneurysms have been treated with clipping (4,5,11-13,17). Clipping of multiple aneurysms in MIA, however, results in poorer outcomes than in a single aneurysm (5, (11) (12) (13) 17) . This can be explained by the increased manipulation of cerebral arteries and brain tissue during multiple aneurysm surgery (11, 13) . Also, one-stage clipping for multiple aneurysms may be limited in cases where multiple aneurysms are distributed bilaterally, or are in both located in the anterior and posterior circulations (11) .
Unlike clipping, embolizing using coils does not require much manipulation of cerebral arteries or brain tissue. Solander et al. (16) reported that one-stage embolization is safe, whether or not the multiple aneurysms are in the acute phase of bleeding. Our results are in agreement with this study; for all 72 
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and is currently determined empirically. The appearance of the aneurysm (by CT scan and DSA) and the vasospasm of the parent artery should be comprehensive assessed prior to the embolization procedure to identify the aneurysm responsible for bleeding (2,6). The influence of hemodynamics on the course of SAH should also be considered. For example, if an aneurysm's long axis is in the same direction of blood flow, and its vesicle or daughter sac is on the impact point, this aneurysm should be the one considered responsible for the bleeding. For cases where determining the aneurysm responsible for bleeding is difficult, Matouk et al. propose that high definition magnetic resonance (MR) may help (10) . The wall of the ruptured aneurysm would be enhanced on the MR image due to localized vascular endothelial inflammation, and therefore, contrast agent will infiltrate into the vessel wall through the abnormal vascular endothelia. However, MR has its own problems. This method requires high level devices (i.e. operation rooms equipped with both DSA and MR machines) and a lengthy examination procedure requiring intubation anesthesia.
For patients without SAH, whether the unruptured intracranial aneurysms (UIA) should be treated depends on H&H scale, size and location of the aneurysm, age of patient, and relative risk factors for bleeding. Specifically; (i). As UIA smaller than 5 mm, a conservative treatment will be selected, at the same time we will also consider the mental burden of the patient.
(ii). Immediate treatment will be adopted if patient age< 60 and aneurysm size> 5 mm, the age limit will be lifted if aneurysms located at posterior circulation (especially the top of basilar artery) and posterior communicating artery, where much higher risks of bleeding were reported.
(iii). If the aneurysm size is larger than 10 mm, the age criteria could be relaxed to 70 years.
(iv). As the intracavernous internal carotid artery aneurysm demonstrated a less rupture potential can be conservatively treated if the size is less than 10 mm.
(v). Immediate treatment will be adopted for aneurysms with irregular shape, unsmooth edge and/or daughter bubbles formation, which indicate high possibility of bleeding.
(vi). Untreated UIA should be re-examined every year, and immediate treatment will be adopted if the aneurysms enlarged or changed into high-risk shapes.
█ CONCluSION
This initial clinical study substantiates the claim that one-stage endovascular embolization is a safe and effective method for treating multiple intracranial aneurysms. However, due to the small sample size used in this study, the long-term efficacy of one-stage embolization requires further evaluation.
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